{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:17:42Z","timestamp":1792444662390,"version":"4.5.0"},"reference-count":34,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Background: Necrotizing pneumonia is a severe complication of Mycoplasma pneumoniae pneumonia (MPP) in children. Early recognition remains challenging because initial clinical manifestations are often non-specific, highlighting the need for a practical tool for early risk stratification. Methods: We conducted a single-center retrospective study of hospitalized children with MPP. Data from 2015\u20132023 were used for model development, and patients enrolled in 2024 were reserved for temporal validation. We compared candidate machine-learning algorithms and selected a parsimonious random forest model using routinely available variables obtained during the early hospitalization period. Model performance was evaluated using discrimination, calibration, and decision curve analysis, and model interpretability was assessed using SHapley Additive exPlanations (SHAP). Results: The random forest model showed good discriminatory performance in internal validation and retained acceptable performance in the 2024 temporal cohort. Calibration indicated reasonable agreement between predicted and observed risks. Decision curve analysis suggested potential clinical value as a supportive tool for early risk stratification. SHAP analysis highlighted fever duration, C-reactive protein, pleural effusion, alanine aminotransferase, and gamma-glutamyl transferase as the main contributors to model prediction. Conclusions: We developed and temporally validated a clinical prediction model for necrotizing pneumonia in children hospitalized with MPP. The model may support early risk stratification using routinely available clinical data, but it is intended to complement rather than replace clinical judgment. External prospective validation is required before routine clinical implementation.<\/jats:p>","DOI":"10.3390\/children13040473","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:40:52Z","timestamp":1774878052000},"page":"473","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Early Prediction of Necrotizing Pneumonia in Children with Mycoplasma Pneumoniae Pneumonia: Development and Temporal Validation of a Clinical Model"],"prefix":"10.3390","volume":"13","author":[{"given":"Ying","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Respiratory, Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing 400014, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushun","family":"Wan","sequence":"additional","affiliation":[{"name":"College of Basic Medicine, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zang","sequence":"additional","affiliation":[{"name":"Department of Respiratory, Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing 400014, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00001432-200104000-00012","article-title":"Mycoplasma pneumoniae infections","volume":"14","author":"Hammerschlag","year":"2001","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1574-6976.2008.00129.x","article-title":"Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections","volume":"32","author":"Atkinson","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/ijmr.IJMR_1582_16","article-title":"Mycoplasma pneumoniae: A significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections","volume":"147","author":"Kumar","year":"2018","journal-title":"Indian J. Med. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"107200","DOI":"10.1016\/j.ijid.2024.107200","article-title":"Critical insights from recent outbreaks of Mycoplasma pneumoniae: Decoding the challenges and effective interventions strategies","volume":"147","author":"Kant","year":"2024","journal-title":"Int. J. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s12519-024-00831-0","article-title":"Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children","volume":"20","author":"Wang","year":"2024","journal-title":"World J. Pediatr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.46747\/cfp.710708487","article-title":"Resistant Mycoplasma pneumoniae in children","volume":"71","author":"Smith","year":"2025","journal-title":"Can. Fam. Physician"},{"key":"ref_7","unstructured":"The Subspecialty Group of Respiratory, The Society of Pediatrics, Chinese Medical Association, The Editorial Board, Chinese Journal of Pediatrics, and China Medicine Education Association Committee on Pediatrics (2024). Guidelines for the management of community-acquired pneumonia in children (2024 revision). Zhonghua Er Ke Za Zhi, 62, 920\u2013930."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Zhu, X., Liu, P., Yu, H., Wang, L., Zhong, H., Xu, M., Lu, L., Jia, R., Su, L., and Cao, L. (2024). An outbreak of Mycoplasma pneumoniae in children after the COVID-19 pandemic, Shanghai, China, 2023. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1427702"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"114420","DOI":"10.1016\/j.jpeds.2024.114420","article-title":"Surge of Pediatric Respiratory Tract Infections after the COVID-19 Pandemic and the Concept of \u201cImmune Debt\u201d","volume":"284","author":"Lenglart","year":"2025","journal-title":"J. Pediatr."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Xu, L., Wang, P., Wang, Y., Liu, B., Xu, X., Yang, Q., Gao, C., Sun, H., Xu, Y., and Xu, Q. (2024). Epidemiological, clinical, and genotypic characteristics of pediatric Mycoplasma pneumoniae infections: An 8-year survey in Suzhou, China in the pre- and post-COVID-19 eras. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1483152"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S2352-4642(24)00236-0","article-title":"The pattern of childhood infections during and after the COVID-19 pandemic","volume":"8","author":"Nygaard","year":"2024","journal-title":"Lancet Child. Adolesc. Health"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Wu, Q., Pan, X., Han, D., Ma, Z., and Zhang, H. (2024). New Insights into the Epidemiological Characteristics of Mycoplasma pneumoniae Infection before and after the COVID-19 Pandemic. Microorganisms, 12.","DOI":"10.3390\/microorganisms12102019"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"101200","DOI":"10.1016\/j.lanmic.2025.101200","article-title":"Macrolide-resistant Mycoplasma pneumoniae resurgence in Chinese children in 2023: A longitudinal, cross-sectional, genomic epidemiology study","volume":"6","author":"Yan","year":"2025","journal-title":"Lancet Microbe"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41479-017-0035-0","article-title":"Necrotizing pneumonia: An emerging problem in children?","volume":"9","author":"Masters","year":"2017","journal-title":"Pneumonia"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ness-Cochinwala, M., and Totapally, B.R. (2025). A Comprehensive Review of Pediatric Necrotizing Pneumonia. Children, 12.","DOI":"10.3390\/children12091248"},{"key":"ref_16","first-page":"51","article-title":"Necrotizing Pneumonia in Children: A Review","volume":"52","author":"Bush","year":"2024","journal-title":"Paediatr. Respir. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/ajrccm.149.1.8111589","article-title":"Bacteremic necrotizing pneumococcal pneumonia in children","volume":"149","author":"Kerem","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.2147\/IDR.S459626","article-title":"Characteristics and Outcomes of Mycoplasma Pneumoniae Pneumonia Associated with Pulmonary Embolism and Necrotizing Pneumonia in Children","volume":"17","author":"Wang","year":"2024","journal-title":"Infect. Drug Resist."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s10096-025-05101-z","article-title":"Clinical characteristics and associated factors of macrolide-resistant mycoplasma pneumoniae pneumonia in children: A systematic review and meta-analysis","volume":"44","author":"Yang","year":"2025","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1002\/ppul.27110","article-title":"Necrotizing pneumonia associated with macrolide-resistant Mycoplasma in a child","volume":"59","author":"Ding","year":"2024","journal-title":"Pediatr. Pulmonol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/ppul.26593","article-title":"Clinical features of severe Mycoplasma pneumoniae pneumonia with pulmonary complications in childhood: A retrospective study","volume":"58","author":"Luo","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"ref_22","first-page":"658","article-title":"A multicenter retrospective study on the etiology of necrotizing pneumonia in children","volume":"59","author":"Zhou","year":"2021","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Chen, Y., Li, L., Wang, C., Zhang, Y., and Zhou, Y. (2023). Necrotizing Pneumonia in Children: Early Recognition and Management. J. Clin. Med., 12.","DOI":"10.3390\/jcm12062256"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Subspecialty Group of Respiratory, The Society of Pediatrics, Chinese Medical Association, China National Clinical Research Center of Respiratory Diseases, and Editorial Board, Chinese Journal of Pediatrics (2025). Evidence-based guideline for the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children (2023). Pediatr. Investig., 9, 1\u201311.","DOI":"10.1002\/ped4.12469"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.2147\/JIR.S413161","article-title":"Risk Prediction Model for Necrotizing Pneumonia in Children with Mycoplasma pneumoniae Pneumonia","volume":"16","author":"Luo","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"ref_27","unstructured":"Lundberg, S., and Lee, S.I. (2017, January 8). A Unified Approach to Interpreting Model Predictions. Proceedings of the NIPS, 2017 Workshop on Machine Learning for the Developing World, Long Beach, CA, USA."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Van Calster, B., McLernon, D.J., van Smeden, M., Wynants, L., and Steyerberg, E.W. (2019). Calibration: The Achilles heel of predictive analytics. BMC Med., 17.","DOI":"10.1186\/s12916-019-1466-7"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: A novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med. Decis. Making"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.2147\/IDR.S419294","article-title":"Clinical Characteristics of Necrotizing Pneumonia Caused by Different Pathogens","volume":"16","author":"Luo","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1038\/s41598-025-88418-1","article-title":"Chest CT characterization of children with necrotizing pneumonia due to Mycoplasma pneumoniae infection","volume":"15","author":"Hou","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e640","DOI":"10.1097\/PCC.0000000000002793","article-title":"Characteristics and Outcomes of Children with Necrotizing Pneumonia","volume":"22","author":"Kobaitri","year":"2021","journal-title":"Pediatr. Crit. Care Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13052-025-02006-7","article-title":"Development and validation of a nomogram for predicting necrotizing pneumonia in children with refractory Mycoplasma pneumoniae pneumonia","volume":"51","author":"Li","year":"2025","journal-title":"Ital. J. Pediatr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"19061","DOI":"10.1038\/s41598-020-76083-5","article-title":"Early prediction of necrotizing pneumonia from mycoplasma pneumoniae pneumonia with large pulmonary lesions in children","volume":"10","author":"Zhou","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/4\/473\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:09:37Z","timestamp":1774948177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/4\/473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["children13040473"],"URL":"https:\/\/doi.org\/10.3390\/children13040473","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,29]]}}}